Biogen Statistics
NASDAQ: BIIBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
217.29-4.86 (-2.19%)
Market open · Delayed 15 min · as of Oct 8, 2:51 PM ET
Biogen by the numbers
Biogen has a market capitalization of $32.10 billion based on 147.75M shares outstanding. Its trailing P/E ratio is 38.6, above the 5-company peer median of 31.3, and its forward P/E is 13.2. The stock trades 0.4% above its 50-day average and 10.9% above its 200-day average.
Average daily trading volume is 1.07M shares, or about $231.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BIIB valuation vs. peer median
| Metric | BIIB | Peer median | Difference |
|---|---|---|---|
| Market cap | $32.10B | $14.62B | +120% |
| P/E (TTM) | 38.6 | 31.3 | +23% |
| Forward P/E | 13.2 | 14.1 | -7% |
| Avg. volume | 1.07M | 2.03M | -47% |
Peer median across 8 companies: RVMD, BNTX, EXEL, NBIX, ARGX, HALO, TECH, IBRX.
Valuation
- Market cap
- $32.10B
- P/E (TTM)
- 38.59
- Forward P/E
- 13.15
- Price / sales (latest FY)
- 3.25
- EPS (TTM)
- $5.63
- Shares outstanding
- 147.75M
Price and trading
- Previous close
- 222.15
- Open
- 220.30
- Day range
- 215.73 – 223.09
- 52-week range
- 138.00 – 230.49
- 52-week change
- +45.95%
- 50-day moving average
- 216.51
- 200-day moving average
- 195.97
- Beta
- —
- Volume
- 614.21K
- Average volume
- 1.07M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 28, 2026
Additional statistics
- Market Cap
- 32.10B
- Pe
- 38.59
- Forward Pe
- 13.15
- Eps
- 5.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 230.49
- Week52 Low
- 138.00
- Avg Volume
- 1.07M
- Shares Outstanding
- 147.75M
- Ma50
- 216.51
- Ma200
- 195.97
- Earnings Date
- Oct 28, 2026
- Pct From52w High
- -5.73%
- Pct From52w Low
- 57.45%